Drug Profile
Tuberculosis vaccine - JN-International Medical Corporation
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator JN-International Medical Corporation
- Class Antituberculars; Recombinant fusion proteins; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Tuberculosis in USA (Parenteral)
- 07 Jul 2016 Early research in Tuberculosis in USA (Parenteral)